Detalhe da pesquisa
1.
High-risk Stage III colon cancer patients identified by a novel five-gene mutational signature are characterized by upregulation of IL-23A and gut bacterial translocation of the tumor microenvironment.
Int J Cancer
; 146(7): 2027-2035, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31693169
2.
[miR-15a and miR-16 modulate drug resistance by targeting bcl-2 in human colon cancer cells].
Zhonghua Zhong Liu Za Zhi
; 36(12): 897-902, 2014 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-25623762
3.
Decreased expression of H19/miR-675 ameliorates hypoxia-induced oxaliplatin resistance in colorectal cancer.
Heliyon
; 10(5): e27027, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38449593
4.
HOTAIR/miR-1277-5p/ZEB1 axis mediates hypoxia-induced oxaliplatin resistance via regulating epithelial-mesenchymal transition in colorectal cancer.
Cell Death Discov
; 8(1): 310, 2022 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798695
5.
Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.
J Cancer
; 10(26): 6618-6634, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31777591
6.
PTPRB promotes metastasis of colorectal carcinoma via inducing epithelial-mesenchymal transition.
Cell Death Dis
; 10(5): 352, 2019 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31040266
7.
Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target.
Cancer Commun (Lond)
; 42(2): 164-169, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862750